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In this article, we review the clinical and histological spectrum of the renal angiomy-
olipoma (AML). Clinically, AMLs are subdivided into sporadic type and tuberous-
sclerosis-associated type. Histologically, AMLs are subcategorized into classic, 
epithelioid, oncocytic, and cystic types.
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1.  Introduction
Renal angiomyolipomas (AMLs) exhibit a considerably 
broad spectrum, from simply an imaging curiosity to a 
life-threatening condition.1–3 AMLs account for approxi-
mately 1% of surgically resected renal neoplasms.1,4 To 
date, several variants have been described including 
classic, epithelioid, oncocytic, and cystic types. In this ar-
ticle, we present a general overview of these subtypes.
2.  Sporadic AMLs and AMLs With 
Tuberous Sclerosis
Among AML cases, 50–70% are sporadic. AMLs of the 
sporadic type affect elderly patients in the 4th to 6th dec-
ades with a female predominance (4:1). These patients 
typically present with flank pain, hematuria, and a renal 
mass. AMLs of the sporadic type are mostly single and 
unilateral.1,4 On the other hand, the remaining 30–50% 
of cases are associated with tuberous sclerosis. Tumors 
associated with tuberous sclerosis preferentially occur 
in females in the 3rd to 4th decades. AMLs are generally 
asymptomatic and incidentally discovered by imaging 
analyses. The lesions associated with tuberous sclerosis 
tend to be small, bilateral, and multifocal.1,4
3.  Classic (triphasic) Type of AML
Renal AMLs are histologically characterized by a mixture 
of smooth muscle cells, adipocyte cells, and blood 
vessels in various proportions (Figure 1A and 1B).1,2 
Fat-predominant AMLs are detected as a diffuse hypo-
echoic mass by ultrasono graphy. Multidirectional com-
puted tomography of frequency-selective fat-suppressed 
pulse sequences at magnetic resonance imaging may 
detect a macroscopic adipose component. However, fat-
poor AMLs, which comprise < 5% of all AMLs, may be 
difficult to distinguish from other renal neoplasms by 
imaging analyses.4 Approximately 25% of AMLs may 
manifest spontaneous rupture and hemorrhaging.1,4 
Renal AMLs have long been considered benign hamarto-
mas, but now there is evidence indicating that renal 
AMLs are monoclonal neoplasms arising from pluripo-
tent mesenchymal stem cells or uncommitted cells.5,6 
Immunohistochemi cally, tumor cells possess the immu-
nophenotypes of both smooth muscle cells and melano-
cytic cells, namely, melanosomes, melan-A, MART-1 
CD63, smooth muscle actin, calponin, and muscle-
specific actin.1,2 Adipocyte cells may be posi tive for S-100 
protein.2 AMLs usually behave in a benign fashion, but 
cases behaving in an aggressive fashion have also been 
reported.7,8
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4.  Epithelioid Type of AML
This variant shows sheets of oval to polygonal epithelioid 
cells with a clear to eosinophilic cytoplasm (Figure 2A).9 
Histologically, epithelioid neoplastic cells are categorized 
into small-, intermediate-, and large-cell types based on 
the cell size.10 Thick-walled blood vessels are often ob-
served.9 In some cases, hemorrhaging, coagulative tumor 
necrosis, nuclear atypia, mitoses, and atypical mitoses 
may be seen.9,10 Immunohistochemically, neoplastic cells 
express smooth muscle markers and melanocytic markers 
including melanosomes, melan A, MART-1, and micro-
phthalmia-associated transcription factor (Figure 2B).11 
In two previous reports, one third of epithelioid AMLs 
behaved in a malignant fashion.4,12 An increased mitotic 
count and the presence of atypical epithelioid cells and 
atypical mitoses are thought to be associated with malig-
nant behavior.12 In contrast, all cases reported in a series 
by Adyin et al had a benign clinical outcome.10
5.  Oncocytic Type of AML
Oncocytic AMLs consist of sheets of densely packed, 
medium-sized and large, deeply eosinophilic to oncocytic 
cells that resemble a renal oncocytoma.13 Recognition 
of this variant is important given that renal oncocytomas 
also occur more frequently in patients with tuberous 
sclerosis than sporadic cases. Furthermore, an association 
of AMLs with renal oncocytomas has been reported 
even in patients without tuberous sclerosis.14,15
6.  Cystic Type of AML (AMLs With Epithelial 
Cysts; AMLECs)
Cystic AMLs, also known as AMLECs, consist of three ele-
ments: epithelial cysts lined by cuboidal to hobnail cells, 
a compact subepithelial “cambium-like” layer of cellular, 
Müllerian-like stroma with prominent admixed chronic 
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Figure 1  Macroscopic findings of a classic angiomyolipoma. (A) Smooth muscle cells and fat tissue are shown. (B) A thick-walled 
vessel can be seen.
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Figure 2  Macroscopic findings of an epithelioid angiomyolipoma. (A) Sheets of oval to polygonal cells are shown, and entrapped 
tubules can be focally identified. (B) Neoplastic cells are positive for melanosomes.
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inflammation, and muscle-predominant AMLs containing 
a dysmorphic blood exterior to the cellular subepithelial 
stroma (Figure 3).16,17 An epithelial component often 
forms various-sized cysts and immunohistochemical 
methods can show the phenotype of the collecting duct 
system. However, whether the epithelial component is 
neoplastic in nature or actually represents an entrapped 
collecting duct is debatable. Sub-epithelial stromal cells 
show immunolabeling for the estrogen receptor, proges-
terone receptor, and CD10, suggesting differentiation 
toward endometrial stromal cells.16,17
In conclusion, a total nephrectomy, partial nephrec-
tomy, ablation, or arterial embolization is selected as 
treatment for renal AMLs according to the size and 
number of tumors, patient’s symptoms, and the associa-
tion with tuberous sclerosis.4 Recently, close relationships 
among renal AMLs, malignant melanomas, and renal 
carcinoma associated with Xp11.2 translocations/TFE3 
gene fusions (Xp11.2 renal cell carcinoma) have been 
suggested.18–20 Accordingly, the majority of previously 
reported epithelioid AMLs (perivascular epithelioid cell 
tumors) with malignant behavior can be included in a 
category of renal tumors with overlapping features with 
Xp11.2 renal cell carcinomas. The histological spectrum 
of AMLs may be further broadened in the near future. 
Further large-scale investigations are required to clarify 
the nature of renal AMLs.
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Figure 3 Microscopic findings of a cystic angiomyolipoma. 
Epithelial cells with a cystic pattern and hobnail appearance 
are shown.
